Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on February 19, 2008

Hypertension. 2008
Published online before print February 19, 2008, doi: 10.1161/HYPERTENSIONAHA.107.103648
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v51,pe32)
Right arrow Correction (v51,pe33)
Right arrow All Versions of this Article:
51/4/867    most recent
HYPERTENSIONAHA.107.103648v3
HYPERTENSIONAHA.107.103648v2
HYPERTENSIONAHA.107.103648v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyer, A. M.
Right arrow Articles by Faraci, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyer, A. M.
Right arrow Articles by Faraci, F. M.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies

Submitted on October 17, 2007
Revised on November 10, 2007

Interference With PPAR{gamma} Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling

Andreas M. Beyer; Gary L. Baumbach; Carmen M. Halabi; Mary L. Modrick; Cynthia M. Lynch; Thomas D. Gerhold; Shams M. Ghoneim; Willem J. de Lange; Henry L. Keen; Yau-Sheng Tsai; Nobuyo Maeda; Curt D. Sigmund*; and Frank M. Faraci*

From the Genetics Graduate Program (A.M.B., C.M.H.), the Department of Pathology (G.L.B., T.D.G., S.M.G.), the Department of Internal Medicine (M.L.M., C.M.L., W.J.d.L., H.L.K., C.D.S., F.M.F.), the Department of Molecular Physiology and Biophysics (C.D.S.), the Center on Functional Genomics of Hypertension (C.D.S.), and the Department of Pharmacology (F.M.F.), Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City; and the Department of Pathology (Y.-S.T., N.M.), University of North Carolina, Chapel Hill.

* To whom correspondence should be addressed. E-mail: curtsigmund{at}uiowa.edu or frank-faraci{at}uiowa.edu.

Abstract—The transcription factor PPAR{gamma} is expressed in endothelium and vascular muscle where it may exert antiinflammatory and antioxidant effects. We tested the hypothesis that PPAR{gamma} plays a protective role in the vasculature by examining vascular structure and function in heterozygous knockin mice expressing the P465L dominant negative mutation in PPAR{gamma} (L/+). In L/+ aorta, responses to the endothelium-dependent agonist acetylcholine (ACh) were not affected, but there was an increase in contraction to serotonin, PGF2{alpha}, and endothelin-1. In cerebral blood vessels both in vitro and in vivo, ACh produced dilation that was markedly impaired in L/+ mice. Superoxide levels were elevated in cerebral arterioles from L/+ mice and responses to ACh were restored to normal with a scavenger of superoxide. Diameter of maximally dilated cerebral arterioles was less, whereas wall thickness and cross-sectional area was greater in L/+ mice, indicating cerebral arterioles underwent hypertrophy and remodeling. Thus, interference with PPAR{gamma} signaling produces endothelial dysfunction via a mechanism involving oxidative stress and causes vascular hypertrophy and inward remodeling. These findings indicate that PPAR{gamma} has vascular effects which are particularly profound in the cerebral circulation and provide genetic evidence that PPAR{gamma} plays a critical role in protecting blood vessels.


Key words: endothelial function • dominant negative • hypertension • remodeling • hypertrophy




This article has been cited by other articles:


Home page
EndocrinologyHome page
V. T. Todorov, M. Desch, T. Schubert, and A. Kurtz
The Pal3 Promoter Sequence Is Critical for the Regulation of Human Renin Gene Transcription by Peroxisome Proliferator-Activated Receptor-{gamma}
Endocrinology, September 1, 2008; 149(9): 4647 - 4657.
[Abstract] [Full Text] [PDF]